Wise Words Wednesday Blog This series features answers to some of the most frequently asked questions our pharmacists receive, as…
On October 20, 2022, Health Canada granted approval for SKYRIZI® (risankizumab) as the latest addition for the treatment of moderate-severe Crohn’s disease.…
We have had many calls asking about the timing of vaccines this fall. As clinical pharmacists working at Charlton Health,…